Combination of Simvastatin and Metformin Reduces Triple-Negative Breast Cancer Tumor Growth Through AKT/AMPK/ACC Signaling Axis.

Chemotherapy continues to be the standard of care for metastatic malignancies, such as triple-negative breast cancer (TNBC). Although the treatment strategy increases survival rates marginally, it frequently leads to the development of resistant dise…

Preview only. Read the full abstract at the source